Hutox 200 Units

Hutox utilizes advanced chromatography purification (US Patent No. 9,447,214) to achieve 99% neurotoxin purity with reduced protein load (≤5ng/). The formulation contains 900kDa complex molecular weight neurotoxin with preserved biological activity. Third-party testing confirms ≤0.3% diffusion radius from injection site and 98.7% receptor binding efficiency in clinical models. Manufactured under and EU standards with full traceability.

Pharmaceutical Specifications

• Active Substance: Botulinum Toxin Type A 200U/
• Excipients: Human serum albumin (0.5mg), NaCl (0.9mg)
• Packaging: Glass with rubber stopper (Type I glass)
• Production Standard:, EU Grade A
• Storage: -20°C (long-term), 2-8°C (in-use)
• Shelf Life: 24 months at -20°C
• Reconstitution: Use preservative-free 0.9% NaCl (2.5ml per 100U)
• Gauge: 30-32G for facial, 25-27G for limb injections
• Injection Volume: 0.05-0.1ml per site (cosmetic), 0.2-0.5ml (therapeutic)
• Dosing: 20-40U for glabellar, 60-100U for upper limb spasticity
• Onset: 24-72 hours (initial), peak at 2 weeks